USPSTF2021EN
Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement.
Zusammenfassung
US PREVENTIVE SERVICES TASK FORCE RECOMMENDATION STATEMENT
TITLE: Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement.
PUBLICATION: JAMA, 2021
PMID: 34374716
RECOMMENDATION SUMMARY:
Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are used. Pregnant persons with
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
USPSTF2021
USPSTF: Gestational Diabetes: Screening (Grade B)
USPSTF2021
USPSTF: Gestational Diabetes Mellitus: Screening (Grade B, 2021)
USPSTF2021
Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.
USPSTF2023
Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
USPSTF2017
Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.
USPSTF2022
Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
USPSTF2021
Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement.
WHO2013